Company profile: AmniSure
1.1 - Company Overview
Company description
- Provider of the AmniSure ROM Test, a one-step, minimally invasive diagnostic strip that uses proprietary technology to detect tiny quantities of amniotic fluid in vaginal discharge. FDA-cleared for marketing, reimbursable under most U.S. state Medicaid plans, and approved in other markets; AmniSure International manufactures, markets, and distributes the test worldwide.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AmniSure
Mammoth Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-based diagnostics, therapeutics, and protein discovery solutions. The DETECTR Platform delivers instrument-free nucleic acid detection for disease; therapeutics offer precision genome editing using novel CRISPR-Cas enzymes; and a proprietary platform discovers new CRISPR systems and Cas proteins for applications in research, agriculture, and biodefense.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mammoth Biosciences company profile →
OncoMethylome
HQ: Belgium
Website
- Description: Provider of molecular diagnostics focused on developing gene methylation tests for early detection of cancer and personalized treatment decisions, offering novel, accurate, and informative diagnostic tools for treating physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoMethylome company profile →
Phthisis Diagnostics
HQ: United States
Website
- Description: Provider of molecular diagnostics products for various infectious diseases, leveraging molecular technology to deliver superior quality, ease of use, and cost savings for laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phthisis Diagnostics company profile →
OPX Biotechnologies
HQ: United States
Website
- Description: Provider of bioengineering technology to convert renewable feedstocks into biofuels and green chemistry products, leveraging its proprietary OPX EDGE (Efficiency Directed Genome Engineering) platform for rapid, rational, and robust optimization of microbes and bioprocesses; Colorado-based.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OPX Biotechnologies company profile →
Stoke Therapeutics
HQ: United States
Website
- Description: Provider of antisense oligonucleotide therapies that modulate RNA splicing to increase gene expression. Offerings include STK-001, in clinical testing for Dravet syndrome to boost protein from the healthy gene; STK-002 for autosomal dominant optic atrophy to elevate OPA-1; and the TANGO platform to increase protein from healthy genes across diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stoke Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AmniSure
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AmniSure
2.2 - Growth funds investing in similar companies to AmniSure
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AmniSure
4.2 - Public trading comparable groups for AmniSure
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →